Challenges in nuclear medicine: innovative theranostic tools for personalized medicine

Challenges in nuclear medicine: innovative theranostic tools for personalized medicine

Bibliographic Details
Main Authors:	Françoise eKraeber-Bodéré, Jacques eBarbet
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-07-01
Series:	Frontiers in Medicine
Subjects:	Nuclear Medicine personalized medicine targeted therapies FDG-PET PET imaging
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fmed.2014.00016/full

Similar Items

THERANOSTICS: NUCLEAR MEDICINE IN PROSTATE CANCER
by: Marina Camargo ETCHEBEHERE, et al.
Published: (2024-04-01)

Editorial: Nuclear Medicine in the Context of Personalized Medicine
by: Jacques Barbet, et al.
Published: (2020-06-01)

QUANTITATIVE EVALUATION OF THERAPEUTIC RESPONSE BY FDG PET-CT IN METASTATIC BREAST CANCER
by: Dorothée eGOULON, et al.
Published: (2016-05-01)

Pretargeting for imaging and therapy in oncological nuclear medicine
by: Clément Bailly, et al.
Published: (2017-06-01)

Interest of Pet Imaging in Multiple Myeloma
by: Bastien Jamet, et al.
Published: (2019-04-01)

Prognostic value and clinical impact of 18FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy.
by: clement eBailly, et al.
Published: (2014-12-01)

Editorial: A year in review: discussions in nuclear medicine
by: Domenico Albano, et al.
Published: (2024-02-01)

Recent applications of nuclear medicine in diagnostics (I part)
by: Giorgio Treglia, et al.
Published: (2013-04-01)

Editorial: Nuclear medicine in rheumatological diseases' therapy and diagnosis
by: Giorgio Treglia, et al.
Published: (2023-03-01)

Paraneoplastic ocular sarcoidosis in the setting of recurrent rectal carcinoid tumor diagnosed by F18-fluorodeoxyglucose PET CT
by: Elizabeth D. Marlow, M.D., et al.
Published: (2020-12-01)

Immuno-PET: Design options and clinical proof-of-concept
by: Alexandre Lugat, et al.
Published: (2022-10-01)

The Role of Nuclear Medicine in The Diagnosis and Management of Solitary Pulmonary Nodules
by: Keyvan Sadri, et al.
Published: (2013-10-01)

The Role of Nuclear Medicine in The Diagnosis and Management of Solitary Pulmonary Nodules
by: Farzaneh Shariati, et al.
Published: (2013-10-01)

Radiolabeled Dendrimers for Nuclear Medicine Applications
by: Lingzhou Zhao, et al.
Published: (2017-08-01)

Interest of FDG-PET in the Management of Mantle Cell Lymphoma
by: Clément Bailly, et al.
Published: (2019-04-01)

Radioembolization: Emerging Opportunities in the Era of Personalized Medicine
by: Cicero Matthew R Habito
Published: (2015-10-01)

CLINICAL AND SURVIVAL IMPACT OF FDG PET IN PATIENTS WITH SUSPICION OF RECURRENT OVARIAN CANCER: A 6-YEAR FOLLOW-UP
by: Daniela eRusu, et al.
Published: (2015-07-01)

PET-Assessed Metabolic Tumor Volume Across the Spectrum of Solid-Organ Malignancies: A Review of the Literature
by: Anusha Agarwal, et al.
Published: (2025-01-01)

Theranostics Nuclear Medicine in Prostate Cancer
by: Helena Lima, et al.
Published: (2024-11-01)

Editorial: Nuclear medicine advances through artificial intelligence and intelligent informatics
by: Lisa M. Duff, et al.
Published: (2025-01-01)

COMPARISON OF PET/CT IMAGES WITH 18F-FDG AND 18F-PSMA-1007 IN MUSCULOSKELETAL TUMORS TO EVALUATE THE POTENTIAL OF THERANOSTICS APPROACH
by: Mayara Branco E. Silva, et al.
Published: (2024-04-01)

The Role of Positron Emission Tomography- Computed Tomography/Magnetic Resonance Imaging in Modern Medicine
by: Sina Houshmand, et al.
Published: (2014-09-01)

Editorial: Reviews in: nuclear medicine 2023
by: Chuen-Yen Lau, et al.
Published: (2024-12-01)

The changing landscape of nuclear medicine and a new era: the “NEW (Nu) CLEAR Medicine”: a framework for the future
by: Mehdi Djekidel
Published: (2023-06-01)

Editorial: “Nuclear medicine in cancer diagnosis”
by: Francesco Cicone, et al.
Published: (2022-09-01)

Editorial: Insights in nuclear medicine: 2022
by: Giorgio Treglia, et al.
Published: (2023-07-01)

FDG-PET AND PET/CT - Part I
by: Amol M Takalkar, et al.
Published: (2007-07-01)

Performance of [<sup>18</sup>F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis
by: Giorgio Treglia, et al.
Published: (2024-07-01)

Relationship between Baseline [<sup>18</sup>F]FDG PET/CT Semiquantitative Parameters and BRCA Mutational Status and Their Prognostic Role in Patients with Invasive Ductal Breast Carcinoma
by: Francesco Dondi, et al.
Published: (2022-10-01)

Dynamic FDG PET/CT on bladder paraganglioma: A case report
by: Makoto Taninokuchi Tomassoni, et al.
Published: (2022-10-01)

Nuclear medicine
Published: (1964)

Nuclear medicine
Published: (1964)

Analysis of continuous infusion functional PET (fPET) in the human brain
by: Shenpeng Li, et al.
Published: (2020-06-01)

The role of 18F-FDG PET/CT in the management of large-vessel vasculitis: applications and limitations in clinical practice
by: Maria V. Mattoli, et al.
Published: (2012-01-01)

From Bench to Bedside: Patient-Oriented Radiopharmaceutical Development in Nuclear Medicine Based on the Example of [<sup>89</sup>Zr]Zr-PSMA-DFO
by: Klaus Schomäcker, et al.
Published: (2023-12-01)

Optimized 18F-FDG PET-CT Method to Improve Accuracy of Diagnosis of Metastatic Cancer
by: Richard Black, et al.
Published: (2023-04-01)

Occupational radiation dose assessment for nuclear medicine workers in Turkey: A comprehensive investigation
by: Wiam Elshami, et al.
Published: (2022-06-01)

Positron Emission Tomography in Breast Cancer
by: Jose Luis Vercher-Conejero, et al.
Published: (2015-03-01)

18F-fluorodeoxyglucose and 18F-flumazenil positron emission tomography in patients with refractory epilepsy
by: Hodolic Marina, et al.
Published: (2016-09-01)

Editorial: Global excellence in nuclear medicine: North America
by: Abhishek Jha, et al.
Published: (2023-10-01)